Robyn Saw

26PUBLICATIONS
149CO-AUTHORS
Predictive and prognostic markersCommunication studiesMolecular targetsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Disease surveillance
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (26)

|Jan 29, 2026
A randomised pilot trial of perioperative propranolol combined with celecoxib versus standard of care in stage III melanoma: The ProCel study protocol.

Katina J Selvaraj, Diona L Damian, J Guy Lyons

|Jan 28, 2026
Neoadjuvant ipilimumab plus nivolumab in melanoma: 5-year survival and biomarker analysis from the phase 2 PRADO-trial.

Lotte L Hoeijmakers, Petros Dimitriadis, Steven C M A Wijnen

|Dec 27, 2025
Effectiveness of a stepped-care model to address fear of cancer recurrence in patients with early-stage melanoma: results at 6- and 12-month follow-up.

Jake R Thompson, Lisa Gomes, Grace Kouvelis

|Dec 18, 2024
Patient and Staff Experiences of Embedding Electronic Patient Reported Outcome Measures for Distress Screening and Quality of Life Assessment, Into Routine Melanoma Care: A Mixed-Methods Study.

Kathy Dempsey, Robyn Saw, Iris Bartula

|Dec 16, 2024
Short-Term Effectiveness of a Stepped-Care Model to Address Fear of Cancer Recurrence in Patients With Early-Stage Melanoma.

Jake R Thompson, Lisa Gomes, Grace Kouvelis

|Jun 21, 2024
Neoadjuvant pembrolizumab, dabrafenib and trametinib in BRAF<sup>V600</sup>-mutant resectable melanoma: the randomized phase 2 NeoTrio trial.

Georgina V Long, Matteo S Carlino, George Au-Yeung

Pageof 5

Frequent Collaborators

16 joint publications

Richard A Scolyer

12 joint publications

Serigne N Lo

12 joint publications

Georgina V Long

9 joint publications

Kerwin F Shannon